[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"congenital-hyperinsulinism-chi\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:congenital-hyperinsulinism-chi":20},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":4,"targetDuration":4,"studyType":17,"phases":4,"briefSummary":18,"conditions":19,"keywords":23,"overallStatus":38,"whyStopped":4,"lastUpdateSubmitDate":39,"lastUpdatePostDateStruct":40,"startDateStruct":4,"completionDateStruct":4,"leadSponsor":43,"locationsCount":5},"100202772","18f-l-fluoro-dopa-petct-scan-localization-of-focal-pancreatic-lesions-in-subjects-with-hyperinsulinemic-hypoglycemia-100202772",false,"NCT01916148","18F-L-Fluoro-DOPA PET\u002FCT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia","Expanded Access Use of 18F-L-Fluoro-DOPA PET\u002FCT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia","Inclusion Criteria:\n\n* Subjects of any age with hyperinsulinemic hypoglycemia, diagnosed by a fasting test and\u002For response to glucagon stimulation.\n* Subjects who are eligible for pancreatic surgery regardless of prior pancreatic surgery\n\nExclusion Criteria:\n\n* Pregnant or lactating females\n* Any other major illness or condition that in the investigator's judgment will substantially increase the risk associated with the subject's participation in this study\n* Subjects who are not a candidate for pancreatic surgery","ALL","EXPANDED_ACCESS","This purpose of this study is to determine the ability of an 18F-fluoro-L-dihydroxyphenylalanine (18F-DOPA) PET (Positron Emission Tomography) scan to detect a focal lesion of hyperinsulinism and determine the location in patients with congenital hyperinsulinism, Beckwith Wiedemann Syndrome and suspected insulinoma. Safety data will be collected.",[20,21,22],"Congenital Hyperinsulinism (CHI)","Beckwith-Wiedemann Syndrome","Insulinoma",[24,25,26,27,28,29,30,31,32,33,34,35,36,37],"Hypoglycemia","Hyperinsulinism (HI)","F-DOPA","PET","18-F DOPA","18F-L-Fluoro-DOPA","18F-fluoro-L-dihydroxyphenylalanine","focal pancreatic lesions","congenital hyperinsulinism","Beckwith Wiedemann Syndrome","insulinoma","Hyperinsulinemic Hypoglycemia","F-DOPA PET","CHI (Congenital hyperinsulinism)","AVAILABLE","2026-04-22",{"date":41,"type":42},"2026-04-27","ACTUAL",{"name":44,"class":45},"Children's Hospital of Philadelphia","OTHER"]